Neurotrophic gene polymorphisms and response to psychological therapy
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Therapygenetics, the study of genetic determinants of response to psychological therapies, is in its infancy. Here, we investigate whether single-nucleotide polymorphisms in nerve growth factor (NGF) (rs6330) and brain-derived neutrotrophic factor (BDNF) (rs6265) genes predict the response to cognitive behaviour therapy (CBT). Neurotrophic genes represent plausible candidate genes: they are implicated in synaptic plasticity, response to stress, and are widely expressed in brain areas involved in mood and cognition. Allelic variation at both loci has shown associations with anxiety-related phenotypes. A sample of 374 anxiety-disordered children with white European ancestry was recruited from clinics in Reading, UK, and in Sydney, Australia. Participants received manualised CBT treatment and DNA was collected from buccal cells using cheek swabs. Treatment response was assessed at post-treatment and follow-up time points. We report first evidence that children with one or more copies of the T allele of NGF rs6330 were significantly more likely to be free of their primary anxiety diagnosis at follow-up (OR = 0.60 (0.42-0.85), P = 0.005). These effects remained even when other clinically relevant covariates were accounted for (OR = 0.62 (0.41-0.92), P = 0.019). No significant associations were observed between BDNF rs6265 and response to psychological therapy. These findings demonstrate that knowledge of genetic markers has the potential to inform clinical treatment decisions for psychotherapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Merikangas, K. R., He, J.-P., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., Benjet, C., Georgiades, K., & Swendsen, J. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.05.017 · Cited by 6,278
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Kim-Cohen, J., Caspi, A., Moffitt, T. E., Harrington, H., Milne, B. J., & Poulton, R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.709 · Cited by 2,025
Baxter, L. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090009002 · Cited by 1,293
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
Goldapple, K., Segal, Z., Garson, C., Lau, M., Bieling, P., Kennedy, S., & Mayberg, H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.34 · Cited by 1,068
Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06690.2003 · Cited by 1,045
Cognitive behavioural therapy for anxiety disorders in children and adolescents
James, A. C., James, G., Cowdrey, F. A., Soler, A., & Choke, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004690.pub4 · Cited by 876
Anxiety Disorders During Childhood and Adolescence: Origins and Treatment
Rapee, R. M., Schniering, C. A., & Hudson, J. L. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153628 · Cited by 821 · cited 1×
“The most convincing predictors are increased symptom severity, 10 parental psycho-pathology 11,12 and comorbid mood disorders.”
Self-citationInteraction between BDNF and Serotonin: Role in Mood Disorders
Martinowich, K., & Lu, B. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301571 · Cited by 793
Role of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667 · cited 1×
“20 21–23 A non-synonymous single-nucleotide polymorphism in the NGF gene, rs6330, produces an alanine to valine substitution at amino acid position 35, and is thought to affect intracellular processing and secretion of NGF .”
Gatt, J. M., Nemeroff, C. B., Dobson-Stone, C., Paul, R. H., Bryant, R. A., Schofield, P. R., Gordon, E., Kemp, A. H., & Williams, L. M. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.143 · Cited by 525
Paquette, V., Lévesque, J., Mensour, B., Leroux, J.-M., Beaudoin, G., Bourgouin, P., & Beauregard, M. (2003) · NeuroImage · doi:10.1016/s1053-8119(02)00030-7 · Cited by 452
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
Kato, M., & Serretti, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.116 · Cited by 450 · cited 2×
“A better antidepressant treatment response is also observed for the Met variant.(55) To date, no studies have investigated whether neurotrophic gene polymorphisms predict response to purely psychological therapy, despite NGF and BDNF being associated with anxiety responses in humans and neural plasticity and BDNF appe…”
Frodl, T., Schüle, C., Schmitt, G., Born, C., Baghai, T., Zill, P., Bottlender, R., Rupprecht, R., Bondy, B., Reiser, M., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.410 · Cited by 394
LYNEHAM, H. J., ABBOTT, M. J., & RAPEE, R. M. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180465a09 · Cited by 307 · cited 1×
“65 for mood disorders).(60,61) The percentages of children with specific disorders as their (a) primary diagnosis or (b) anywhere in their profile were as follows: separation anxiety disorder”
Self-citationBodden, D. H. M., Bögels, S. M., Nauta, M. H., De Haan, E., Ringrose, J., Appelboom, C., Brinkman, A. G., & Appelboom-Geerts, K. C. M. M. J. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318189148e · Cited by 249
Branchi, I., D’Andrea, I., Fiore, M., Di Fausto, V., Aloe, L., & Alleva, E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.005 · Cited by 227
Hudson, J. L., Rapee, R. M., Deveney, C., Schniering, C. A., Lyneham, H. J., & Bovopoulos, N. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c2401 · Cited by 173 · cited 1×
“65 for mood disorders).(60,61) The percentages of children with specific disorders as their (a) primary diagnosis or (b) anywhere in their profile were as follows: separation anxiety disorder”
Self-citationEfficacy of cognitive-behavioural therapy for children and adolescents with anxiety disorders
Hudson, J. L. (2005) · Behaviour Change · doi:10.1375/bech.2005.22.2.55 · Cited by 38 · cited 2×
“J Am Acad Child Adolesc Psychiatry 2010; 49(10): 980-989.”
Self-citation
Cited by
Exposure and response prevention for obsessive-compulsive disorder: A review and new directions
Simpson, H., & Hezel, D. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_516_18 · Cited by 161
“[60] A series of studies have reported that variants of the BDNF gene are associated with improved treatment outcomes with medication for schizophrenia,[61] with dialectical behavior therapy for borderline personality disorder,[62] and, most recently, with cognitive behavioral therapy (CBT) for children with anxiety d…”
BackgroundLueken, U., Zierhut, K. C., Hahn, T., Straube, B., Kircher, T., Reif, A., Richter, J., Hamm, A., Wittchen, H.-U., & Domschke, K. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.005 · Cited by 133
Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders
Galvez-Contreras, A. Y., Campos-Ordonez, T., Lopez-Virgen, V., Gomez-Plascencia, J., Ramos-Zuniga, R., & Gonzalez-Perez, O. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.08.004 · Cited by 112
Hpa axis related genes and response to psychological therapies: Genetics and epigenetics
Roberts, S., Keers, R., Lester, K. J., Coleman, J. R. I., Breen, G., Arendt, K., Blatter‐Meunier, J., Cooper, P., Creswell, C., Fjermestad, K., et al. (2015) · Depression and Anxiety · doi:10.1002/da.22430 · Cited by 107
“Previous studies investigating both genetic[26, 30, 32] and epigenetic[26, 27] markers of response to psychological therapy have also demonstrated the largest effects at follow-up.”
BackgroundSelf-citationWarren, V. T., Anderson, K. M., Kwon, C., Bosshardt, L., Jovanovic, T., Bradley, B., & Norrholm, S. D. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.10.014 · Cited by 62
Metadata
- Authors
- Lester, K. J., Hudson, J. L., Tropeano, M., Creswell, C., Collier, D. A., Farmer, A., Lyneham, H. J., Rapee, R. M., & Eley, T. C.
- Venue
- Translational Psychiatry
- Published
- 2012-05-01
- Volume
- 2
- Issue
- 5
- Pages
- e108-e108
- ISSN
- 2158-3188 (ISSN-L)
- OpenAlex
- W2100903632
- Cited by
- 62
- References
- 20
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.